Making Innovation Work For Patients

A panel discussion

Although tens of thousands of substances are investigated every year for their potential to tackle diseases, only a handful make it to become a treatment. When they do, patients do not always have access to them as fast as other comparable countries in Europe.

Using a new study, ‘Comparator Report on Cancer in Ireland – Disease Burden, Costs and Access to Medicines’, by the Swedish Institute for Health Economics, we explore how Ireland compares with 14 other western European countries for cancer survival rates.

We investigate the journey a medicine makes from bench to bedside, how public policy can be better tailored to spur and adopt innovation, and how health outcomes can be improved by new medicines.

To view this event please click here.